BPC-157 + KPV
Also known as: BPC-157/KPV blend, BPC-157 KPV
Pre-mixed blend of two component peptides marketed for tissue repair and inflammation. BPC-157 is a synthetic pentadecapeptide (sequence GEPPPGKPADDAGLV) derived from a gastric protective protein, studied in animals for tendon/ligament and GI healing, partly via the VEGFR2/angiogenesis pathway. KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH that acts as an anti-inflammatory agent, primarily by inhibiting NF-kB signaling without melanocortin-receptor activation. Neither component is FDA-approved for human use, and there is no controlled human efficacy or safety data for this specific combination — the rationale is inferred from the individual grey-market research peptides.
Common research uses
Pricing for BPC-157 + KPV
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
No sellers for BPC-157 + KPV are indexed yet — we add vendors and their prices as we find them.
COAs for BPC-157 + KPV
2 third-party tests across 2 vendors. Each card links to the full report.
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.